Acrivon Therapeutics (ACRV) Current Assets (2021 - 2026)
Acrivon Therapeutics' Current Assets came in at $91.49 million for Q2 2026, down 33.9% from $138.41 million a year earlier and down 7.8% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics' Current Assets was $120.45 million, down 33.7% from FY2024.
- Current Assets carries a four-year compound annual growth rate of 4.7% (FY2021 to FY2025).
- Going back by year, Current Assets was $181.63 million in FY2024 (+40.0%), $129.69 million in FY2023 (-1.8%), $132.1 million in FY2022 (+31.6%) and $100.41 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Current Assets since Q3 2022.
- Year-over-year, Current Assets has declined for five consecutive quarters, with an average decline of 6.4% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q3 2023 (growth of 83.7%), and the weakest in Q1 2026 (a decline of 34.4%).
- Business Quant data shows ACRV's Current Assets at $99.22 million (Q1 2026), $120.45 million (Q4 2025) and $130.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Acrivon Therapeutics | 88.27 Mn | 88.27 Mn | - | 91.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.49 Mn |
| Mar 31, 2026 | 99.22 Mn |
| Dec 31, 2025 | 120.45 Mn |
| Sep 30, 2025 | 130.36 Mn |
| Jun 30, 2025 | 138.41 Mn |
| Mar 31, 2025 | 151.33 Mn |
| Dec 31, 2024 | 181.63 Mn |
| Sep 30, 2024 | 188.98 Mn |
| Jun 30, 2024 | 182.36 Mn |
| Mar 31, 2024 | 112.14 Mn |
| Dec 31, 2023 | 129.69 Mn |
| Sep 30, 2023 | 144.49 Mn |
| Jun 30, 2023 | 153.28 Mn |
| Mar 31, 2023 | 123.96 Mn |
| Dec 31, 2022 | 132.10 Mn |
| Sep 30, 2022 | 78.67 Mn |
| Dec 31, 2021 | 100.41 Mn |
API Access
Acrivon Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();